Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity

Medicine and Dentistry

• Acetylsalicylic Acid 33%
• Antiinflammatory Agent 50%
• Caffeic Acid 33%
• Cyclooxygenase 1 Inhibitor 16%
• Cyclooxygenase 2 Inhibitor 16%
• Degenerative Disease 16%
• Dopaminergic Neuron 100%
• Drug Therapy 33%
• Esculetin 33%
• Ibuprofen 16%
• Lipopolysaccharide 100%
• Lipoxygenase 66%
• Lipoxygenase Inhibitor 66%
• Meloxicam 50%
• Microglia 16%
• Neurodegeneration 33%
• Neuroprotective Agent 16%
• Neurotoxicity 100%
• Oxidative Stress 16%
• Parkinson's Disease 50%
• Phenidone 100%
• Side Effect 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acetylsalicylic Acid 33%
• Antiinflammatory Agent 50%
• Caffeic Acid 33%
• COX-2 Inhibitor 16%
• Cyclooxygenase 1 Inhibitor 16%
• Degenerative Disease 16%
• Dopamine Receptor Stimulating Agent 100%
• Esculetin 33%
• Ibuprofen 16%
• Inflammation 16%
• Lipopolysaccharide 100%
• Lipoxygenase 66%
• Lipoxygenase Inhibitor 66%
• Meloxicam 50%
• Nerve Degeneration 33%
• Neuroprotective Agent 16%
• Neurotoxicity 100%
• Parkinson's Disease 50%
• Pharmacotherapy 33%
• Phenidone 100%
• Side Effect 16%

Neuroscience

• Anti-Inflammatory 37%
• Aspirin 25%
• Caffeic Acid 25%
• COX-2 Inhibitor 12%
• Dopaminergic 50%
• Dopaminergic Neuron 100%
• Drug Therapy 25%
• Ibuprofen 12%
• Lipopolysaccharide 100%
• Lipoxygenase 100%
• Meloxicam 37%
• Microglia 12%
• Neurodegeneration 25%
• Neurodegenerative Disorder 12%
• Neuroprotective Agent 12%
• Neurotoxicity 100%
• Oxidative Stress 12%
• Parkinson's Disease 37%
• Side Effect 12%